Global X Genomics & Biotechnology ETF (GNOM)
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
$84.87M
Apr 05, 2019
$0.00
0.00
0.00
0.32%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (10)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (34)
Alnylam Pharmaceuticals, Inc.
ALNY
6.354%
Avidity Biosciences, Inc.
RNA
5.219%
Natera, Inc.
NTRA
4.666%
Ultragenyx Pharmaceutical Inc.
RARE
4.634%
Legend Biotech Corporation
LEGN
4.35%
Myriad Genetics, Inc.
MYGN
4.27%
Bio-Techne Corporation
TECH
4.145%
Veracyte, Inc.
VCYT
3.944%
Sarepta Therapeutics, Inc.
SRPT
3.914%
Illumina, Inc.
ILMN
3.839%
Agilent Technologies, Inc.
A
3.658%
Arrowhead Pharmaceuticals, Inc.
ARWR
3.629%
Intellia Therapeutics, Inc.
NTLA
3.539%
BioMarin Pharmaceutical Inc.
BMRN
3.394%
10x Genomics, Inc.
TXG
3.062%
Beam Therapeutics Inc.
BEAM
2.943%
Rocket Pharmaceuticals, Inc.
RCKT
2.795%
Moderna, Inc.
MRNA
2.451%
CareDx, Inc
CDNA
2.393%
Gilead Sciences, Inc.
GILD
2.134%
Vertex Pharmaceuticals Incorporated
VRTX
2.114%
Vir Biotechnology, Inc.
VIR
1.224%
Sana Biotechnology, Inc.
SANA
1.162%
REGENXBIO Inc.
RGNX
0.899%
Fulgent Genetics, Inc.
FLGT
0.781%
Pacific Biosciences of California, Inc.
PACB
0.645%
Verve Therapeutics, Inc.
VERV
0.537%
Editas Medicine, Inc.
EDIT
0.503%
Allogene Therapeutics, Inc.
ALLO
0.47%
2seventy bio, Inc.
TSVT
0.375%
Poseida Therapeutics, Inc.
PSTX
0.351%
Lyell Immunopharma, Inc.
LYEL
0.268%
Caribou Biosciences, Inc.
CRBU
0.253%
bluebird bio, Inc.
BLUE
0.19%
Sector weights (10)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (34)
Alnylam Pharmaceuticals, Inc.
ALNY
6.354%
Avidity Biosciences, Inc.
RNA
5.219%
Natera, Inc.
NTRA
4.666%
Ultragenyx Pharmaceutical Inc.
RARE
4.634%
Legend Biotech Corporation
LEGN
4.35%
Myriad Genetics, Inc.
MYGN
4.27%
Bio-Techne Corporation
TECH
4.145%
Veracyte, Inc.
VCYT
3.944%
Sarepta Therapeutics, Inc.
SRPT
3.914%
Illumina, Inc.
ILMN
3.839%
Agilent Technologies, Inc.
A
3.658%
Arrowhead Pharmaceuticals, Inc.
ARWR
3.629%
Intellia Therapeutics, Inc.
NTLA
3.539%
BioMarin Pharmaceutical Inc.
BMRN
3.394%
10x Genomics, Inc.
TXG
3.062%
Beam Therapeutics Inc.
BEAM
2.943%
Rocket Pharmaceuticals, Inc.
RCKT
2.795%
Moderna, Inc.
MRNA
2.451%
CareDx, Inc
CDNA
2.393%
Gilead Sciences, Inc.
GILD
2.134%
Vertex Pharmaceuticals Incorporated
VRTX
2.114%
Vir Biotechnology, Inc.
VIR
1.224%
Sana Biotechnology, Inc.
SANA
1.162%
REGENXBIO Inc.
RGNX
0.899%
Fulgent Genetics, Inc.
FLGT
0.781%
Pacific Biosciences of California, Inc.
PACB
0.645%
Verve Therapeutics, Inc.
VERV
0.537%
Editas Medicine, Inc.
EDIT
0.503%
Allogene Therapeutics, Inc.
ALLO
0.47%
2seventy bio, Inc.
TSVT
0.375%
Poseida Therapeutics, Inc.
PSTX
0.351%
Lyell Immunopharma, Inc.
LYEL
0.268%
Caribou Biosciences, Inc.
CRBU
0.253%
bluebird bio, Inc.
BLUE
0.19%